Show simple item record

dc.contributor.advisorPhilip Pallister
dc.contributor.advisorJames Manion
dc.contributor.advisorJohn Christenson
dc.contributor.authorSiddoway, Paul
dc.date.accessioned2020-04-30T10:03:42Z
dc.date.available2020-04-30T10:03:42Z
dc.date.issued1979-04-01
dc.identifier.urihttps://scholars.carroll.edu/handle/20.500.12647/3227
dc.description.abstractThe antiepileptic drug sodium valproate was studied in 19 epileptic patients with uncontrolled seizures of a generalized or partial type. Two-thirds of the patients experienced a reduction in seizure fre uency ranging from 33 to 100%. Adverse effects occurred in 7 (37%) patients and in 4 (21%) the drug had to be discontinued. The most serious adverse effects were platelet reduction and weight gain. Minor adverse effects (e.g. nausea, hair loss, SGOT elevation, ALKOP4 elevation) were always transient.
dc.titleValproic Acid In Epilepsy: Clinical And Adverse Effects
dc.typethesis
carrollscholars.object.degreeBachelor's
carrollscholars.object.departmentLife & Environmental Sciences
carrollscholars.object.disciplinesMedical Pharmacology; Pharmacology
carrollscholars.legacy.itemurlhttps://scholars.carroll.edu/lifesci_theses/485
carrollscholars.legacy.contextkey12662655
carrollscholars.object.seasonSpring
dc.date.embargo12/31/1899 0:00


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record